Boudes Pol F 4
4 · CymaBay Therapeutics, Inc. · Filed Jan 26, 2018
Insider Transaction Report
Form 4
Boudes Pol F
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2018-01-24+125,000→ 125,000 totalExercise: $11.69Exp: 2028-01-23→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option vests as to 1/4 of the underlying shares on January 1, 2019, and vests as to 1/48 of the underlying shares monthly thereafter.